Form 4: Glycomimetics Executive Sells Shares
Insider Transaction (Form 4)
Barbara Harlin Bispham, See Remarks of Glycomimetics Inc, sold 620 shares of common stock on September 16, 2026 for $17.90 per share.
Summary
- Open-market sale: disposed of 620 Ordinary Shares at $17.90 ($11,098) on September 16, 2026; holds 18,710 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $11,098 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Barbara Harlin Bispham — Officer (See Remarks)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Open-market sale | Ordinary Shares | 620 | $18 | $11.1K | 18,710 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Open-market sale (620 shares) |
Keywords
insider transaction, Form 4, CBIO, CRESCENT BIOPHARMA, INC., bearish, Barbara Harlin Bispham
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.